This will probably contribute to the improvement of asthma control and the prevention of acute exacerbations. Triggers of acute exacerbations are generally hard to avoid. Therefore, preexisting ...
The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.
The Nose Knows: Nasal Swab Detects Asthma Type in Kids Jan. 2, 2025 — A new, non-invasive nasal swab test for kids that diagnoses specific asthma subtype, or endotype, could help clinicians ...
Asthma is a serious medical condition that causes inflammation and constriction of the airways. If left untreated, it can affect your quality of life. A severe asthma attack can sometimes be fatal.
AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...